Life-science Early Access Program (LEAP)

Molecular Sensing is offering a fee-based technology evaluation and services program to facilitate applications development and real-time problem solving with researchers interested in immediately tapping into the benefits of BSI technology. We are particularly interested in collaborating with pharmaceutical and life science groups involved in drug discovery seeking solutions to challenging molecular interaction assays that represent key bottlenecks in their research efforts.

Each LEAP collaboration is customized through client consultation with Molecular Sensing R&D staff to set appropriate goals and timelines to evaluate BSI technology in order to advance our clients research interests. The typical LEAP is set-up as a six month program. BSI instrumentation and Molecular Sensing R&D staff are dedicated to each LEAP project. Work is performed at Molecular Sensing's laboratory in the San Francisco Bay area with frequent web based telecom's and reporting of results. Collaborating researchers are encouraged to visit Molecular Sensing during the program for hands-on participation.

At the conclusion of the primary LEAP project, options are available for extended services agreements. Within the next year, we anticipate the option of collaborators taking delivery of commercial shipments of BSI instrumentation. LEAP participants will be given priority to receive the first available instruments.

Targeted Applications

BSI technology has significant applications potential in both kinetic measurements and quantitative molecular interaction based biochemical- and cell-based assays for drug discovery as well as research and diagnostic assays.

Initially LEAP will focus on end-point assays and Kd measurements in drug discovery. Molecular interactions can include biomolecules such as DNA, RNA, proteins, carbohydrates, small drug molecules and lipids along with bacteria, viruses, cells, membrane preps and cell lysates. Experiments are conducted in homogeneous and heterogeneous modes as required. Initial feasibility studies taking several weeks are employed to show technical feasibility of each LEAP project prior to initiating a well planned, extensive fee-based project.

How to Initiate LEAP

The first step to initiate LEAP involves a webinar provided to the client by MSI scientific and business development staff. During the webinar, BSI technology, applications and LEAP details are presented and client project interests are discussed. For more information, please contact one of Molecular Sensing's Business Development Managers or Chief Business Officer, at LEAP@molsense.com to initiate program discussions.

 

 

© 2007, 2008, 2009, Molecular Sensing, Inc. | 1-650-728-8110 | info@molsense.com